NEWS - Porosome Therapeutics, Inc.

Porosome Therapeutics Announces its Patent Estate Review Results: “The strategic analysis confirmed that Porosome Therapeutics occupies a distinct and defensibleintellectual property position within the emerging field of secretion restoration technologies. Porosome Therapeutics has successfully carved out a highly defensible white space” (March 11, 2026)

From the Chairman's Desk (Feb. 23, 2026) Porosome Therapeutics Therapies

From the CEO's DESK (2026)

Porosome Therapeutics Chairman Prof. Dr. Bhanu P. Jena, and Chairman of the Scientific Advisory Board Prof. Dr. Joachim Frank meet with leaders of India’s Science and Technology program and present National Lectures.

From the CEO's DESK (2025)

Porosome Therapeutics Announces Breakthrough Alzheimer’s Discoveries

"State of Science at Porosome Therapeutics, Inc. 2025”, an Introduction by Guillermo Marmol, CEO. Guests in Attendance: J. P. Morgan Executives

Porosome Therapeutics, Inc. Academic Chairman Prof. Bhanu P. Jena presented the Opening Ceremony and Keynote Lecture entitled: “The Porosome Secretory Nanomachine: Discovery to Therapy”, at the International Drug Discovery Science & Technology (IDDST) Congress in Kyoto, Japan

Porosome Therapeutics Unveils Groundbreaking Discovery in Alzheimer’s Disease Research and Treatment

Porosome Therapeutics, Inc. CEO and Chairman are Interviewed in Cambridge, MA

FDA Grants Orphan Drug Designation to Revolutionary Cystic Fibrosis Therapy

Porosome reconstitution therapy: A biologic rescue from cystic fibrosis (In human lung organoids and in CF mice)

1
2
3
4
»